Microangiopathic hemolytic anemia (patient information)

Revision as of 20:51, 31 January 2021 by MydahSajid (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Microangiopathic hemolytic anemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Microangiopathic hemolytic anemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Microangiopathic hemolytic anemia (patient information) On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Microangiopathic hemolytic anemia (patient information)

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Microangiopathic hemolytic anemia (patient information)

on Microangiopathic hemolytic anemia (patient information)

Microangiopathic hemolytic anemia (patient information) in the news

Blogs on Microangiopathic hemolytic anemia (patient information)

Directions to Hospitals Treating Microangiopathic hemolytic anemia

Risk calculators and risk factors for Microangiopathic hemolytic anemia (patient information)

Associate Editor(s)-in-Chief: Mydah Sajid, MD[1]

Overview

Microangiopathic hemolytic anemia is a type of intra-vascular hemolysis that occurs due to a number of diseases. It is a clinical emergency and requires immediate treatment.

What are the symptoms of Microangiopathic hemolytic anemia?

It presents with wide range of clinical symptoms:

What causes Microangiopathic hemolytic anemia?

It is a clinical manifestation of a large number of underlying diseases including:

When to seek urgent medical care?

It is a medical emergency. Any patients presenting with high clinical suspicion should be given immediate treatment.

Diagnosis

The diagnosis of microangiopathic hemolytic anemia is made by carrying out blood tests and visualizing schistocytes on peripheral blood smear. The blood tests show:

Treatment

The treatment of choice is Plasma exchange. Other treatment option include

Possible complications

Acute renal failure, intracranial hemorrhage and myocardial infarction are the possible complications.

References

Template:WH Template:WS